Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.
Med Sci Monit. 2018 Oct 12;24:7295-7302. doi: 10.12659/MSM.910702.
Med Sci Monit. 2018.
PMID: 30312287
Free PMC article.
Retracted.
Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.
Li L, Huizhi L, Binu W, Xinxin D, Longjun W, Liping Y, Yingying Z.
Li L, et al. Among authors: longjun w.
Med Sci Monit. 2022 Jul 19;28:e937840. doi: 10.12659/MSM.937840.
Med Sci Monit. 2022.
PMID: 35850997
Free PMC article.
Item in Clipboard
Cite
Cite